VYNE Therapeutics Inc (VYNE)
2.32
-0.03
(-1.28%)
USD |
NASDAQ |
Apr 23, 16:00
2.21
-0.11
(-4.74%)
Pre-Market: 09:23
VYNE Therapeutics Price to Book Value: 0.3686 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.3686 |
| April 22, 2024 | 0.3734 |
| April 19, 2024 | 0.3575 |
| April 18, 2024 | 0.3654 |
| April 17, 2024 | 0.3813 |
| April 16, 2024 | 0.3845 |
| April 15, 2024 | 0.4083 |
| April 12, 2024 | 0.4401 |
| April 11, 2024 | 0.4767 |
| April 10, 2024 | 0.4258 |
| April 09, 2024 | 0.4385 |
| April 08, 2024 | 0.4354 |
| April 05, 2024 | 0.4497 |
| April 04, 2024 | 0.4512 |
| April 03, 2024 | 0.4926 |
| April 02, 2024 | 0.4798 |
| April 01, 2024 | 0.4894 |
| March 28, 2024 | 0.4878 |
| March 27, 2024 | 0.4703 |
| March 26, 2024 | 0.4497 |
| March 25, 2024 | 0.3925 |
| March 22, 2024 | 0.3845 |
| March 21, 2024 | 0.3702 |
| March 20, 2024 | 0.3464 |
| March 19, 2024 | 0.3321 |
| Date | Value |
|---|---|
| March 18, 2024 | 0.3051 |
| March 15, 2024 | 0.3194 |
| March 14, 2024 | 0.3273 |
| March 13, 2024 | 0.3273 |
| March 12, 2024 | 0.3337 |
| March 11, 2024 | 0.34 |
| March 08, 2024 | 0.3567 |
| March 07, 2024 | 0.3686 |
| March 06, 2024 | 0.3734 |
| March 05, 2024 | 0.3575 |
| March 04, 2024 | 0.3623 |
| March 01, 2024 | 0.3527 |
| February 29, 2024 | 0.3543 |
| February 28, 2024 | 0.3702 |
| February 27, 2024 | 0.3766 |
| February 26, 2024 | 0.3734 |
| February 23, 2024 | 0.3591 |
| February 22, 2024 | 0.3448 |
| February 21, 2024 | 0.3448 |
| February 20, 2024 | 0.3543 |
| February 16, 2024 | 0.3607 |
| February 15, 2024 | 0.3432 |
| February 14, 2024 | 0.3289 |
| February 13, 2024 | 0.3194 |
| February 12, 2024 | 0.3289 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1719
Minimum
Dec 23 2022
17.33
Maximum
Feb 09 2021
2.074
Average
1.100
Median
Oct 02 2023
Price to Book Value Benchmarks
| Viking Therapeutics Inc | 18.73 |
| AN2 Therapeutics Inc | 0.5658 |
| NovaBay Pharmaceuticals Inc | 1.699 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7198 |
Price to Book Value Related Metrics
| PS Ratio | 32.71 |
| Price | 2.32 |
| Earnings Yield | -313.7% |
| Market Cap | 32.71M |